Why could passive Immunoglobulin E antibody therapy be safe in clinical oncology?

Clin Exp Allergy. 2011 Oct;41(10):1337-40. doi: 10.1111/j.1365-2222.2011.03764.x. Epub 2011 May 5.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Animals
  • Antibodies, Monoclonal, Murine-Derived / adverse effects*
  • Basophils / immunology*
  • Carcinoma / therapy*
  • Female
  • Folate Receptor 1 / immunology*
  • Humans
  • Hypersensitivity, Immediate / etiology*
  • Ovarian Neoplasms / therapy*
  • Receptors, IgE / immunology*

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Folate Receptor 1
  • MOv18 monoclonal antibody
  • Receptors, IgE